Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Current Leases (2022 - 2025)

Historic Current Leases for Treace Medical Concepts (TMCI) over the last 4 years, with Q3 2025 value amounting to $2.1 million.

  • Treace Medical Concepts' Current Leases rose 42481.39% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 42481.39%. This contributed to the annual value of $413000.0 for FY2024, which is 7058.4% down from last year.
  • Treace Medical Concepts' Current Leases amounted to $2.1 million in Q3 2025, which was up 42481.39% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Current Leases ranged from a high of $2.1 million in Q3 2025 and a low of $330000.0 during Q3 2022
  • In the last 4 years, Treace Medical Concepts' Current Leases had a median value of $649500.0 in 2022 and averaged $952785.7.
  • Its Current Leases has fluctuated over the past 5 years, first crashed by 7058.4% in 2024, then soared by 43180.66% in 2025.
  • Quarter analysis of 4 years shows Treace Medical Concepts' Current Leases stood at $339000.0 in 2022, then surged by 314.16% to $1.4 million in 2023, then tumbled by 70.58% to $413000.0 in 2024, then surged by 412.11% to $2.1 million in 2025.
  • Its Current Leases was $2.1 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.0 million in Q1 2025.